Algert Global LLC Ani Pharmaceuticals Inc Transaction History

Algert Global LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$58.53 - $68.82 $1.38 Million - $1.63 Million	-23,629 Reduced 64.6%	12,951 $825,000
Q1 2024 May 14, 2024	BUY	$54.2 - $69.69 $1.2 Million - $1.55 Million	22,180 Added 154.03%	36,580 $2.53 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $701,568 - $942,192	14,400 New	14,400 $794,000
Q2 2023 Aug 14, 2023	BUY	$37.29 - $53.83 $248,388 - $358,561	6,661 New	6,661 $359,000
Q1 2019 May 01, 2019	SELL	$45.83 - $70.54 $227,362 - $349,948	-4,961 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$41.17 - $56.44 $919,490 - $1.26 Million	-22,334 Reduced 81.82%	4,961 $223,000
Q3 2018 Nov 14, 2018	SELL	$52.95 - $71.34 $145,030 - $195,400	-2,739 Reduced 9.12%	27,295 $1.54 Million
Q2 2018 Aug 02, 2018	SELL	$56.38 - $68.08 $264,534 - $319,431	-4,692 Reduced 13.51%	30,034 $2.01 Million
Q1 2018 May 03, 2018	BUY	$56.98 - $72.41 $240,512 - $305,642	4,221 Added 13.84%	34,726 $2.02 Million
Q4 2017 Feb 01, 2018	BUY	$53.3 - $74.56 $1.63 Million - $2.27 Million	30,505	30,505 $1.97 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.